Scedosporiosis

• FDA approval · 2026-02-19
  FDA Approved: VFEND — Supplemental Application (Roerig)

  FDA approved a supplemental application for Vfend (voriconazole) submitted by Roerig.

• FDA approval · 2026-01-28
  FDA Approved: VFEND — Supplemental Application (Roerig)

  FDA approved a supplemental application for VFEND (voriconazole) submitted by Roerig.

• CLINICAL_TRIALS research · 2025-11-20
  Clinical Trial Update: Immunomonitoring of Mold Invasive Infections

  A clinical trial evaluating immunomonitoring of mold invasive fungal infections is currently recruiting, sponsored by Assistance Publique - …

• FDA approval · 2023-03-09
  FDA Approved: VORICONAZOLE — Original Application (UBI Pharma Inc.)

  FDA approved a generic version of voriconazole (UBI Pharma Inc.) via Original Application. The approval covers treatment of certain invasive…

• CLINICAL_TRIALS trial_result · 2013-12-17
  Clinical Trial Update: Voriconazole (Vfend) Special Investigation (Regulatory Post Marketing Commitment Plan)

  Completed regulatory post-marketing commitment trial of voriconazole for Scedosporiosis; results posted in 2013.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2010-11-21
  FDA Approved: VFEND — Supplemental Application (Roerig)

  FDA approved a supplemental application for VFEND (voriconazole) submitted by Roerig. The supplement updates the labeling for the antifungal…